Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-05-31
2005-05-31
Raymond, Richard L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S312000, C546S194000, C546S318000
Reexamination Certificate
active
06900232
ABSTRACT:
The present invention relates to a class of compounds represented by the Formula IWherein A1is a pyridinyl of the formulaoptionally substituted by one or more Rkselected from the group consisting of hydroxy, alkyl, alkoxy, alkoxyalkyl, thioalkyl, haloalkyl, cyano, amino alkylamino, halogen, acylamino, sulfonamide and —COR; and R is hydroxy, alkoxy, alkyl or amino; and pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising compounds of the Formula I, and methods of selectively inhibiting or antagonizing the αvβ3and/or αvβ5integrin.
REFERENCES:
patent: 3654306 (1972-04-01), German
patent: 5665754 (1997-09-01), Feldman et al.
patent: 5741796 (1998-04-01), Hartman et al.
patent: 5773646 (1998-06-01), Chandrakumar et al.
patent: 5849736 (1998-12-01), Wityak et al.
patent: 5852210 (1998-12-01), Chen et al.
patent: 0 478 328 (1996-01-01), None
patent: 0747346 (2000-02-01), None
patent: 0 671 392 (2001-02-01), None
patent: 2 264 115 (1993-08-01), None
patent: 10287634 (1998-10-01), None
patent: WO 93/21166 (1993-10-01), None
patent: WO9427947 (1994-12-01), None
patent: WO9503288 (1995-02-01), None
patent: WO 95/32710 (1995-12-01), None
patent: WO 96/41795 (1996-12-01), None
patent: WO 97/12878 (1997-04-01), None
patent: WO9719049 (1997-05-01), None
patent: WO 98/20871 (1998-05-01), None
patent: WO 98/31359 (1998-07-01), None
patent: WO 99/45927 (1999-09-01), None
patent: WO0033838 (2000-06-01), None
patent: WO 00/38665 (2000-07-01), None
patent: WO 00/38715 (2000-07-01), None
patent: WO 00/38719 (2000-07-01), None
patent: WO 00/38786 (2000-07-01), None
patent: WO 00/64888 (2000-11-01), None
patent: WO0068195 (2000-11-01), None
patent: WO 01/14337 (2001-03-01), None
patent: WO 01/14338 (2001-03-01), None
J. Wityak et. al.,Discovery of Potent Isoxazoline Glycoprotein IIb/IIIa Receptor Antagonists,1997, J. Med. Chem. 40, 50-60.
W. H. Miller et. al.,Discovery of Orally Active Nonpeptide Vitronectin Receptor Antagonists Based on a 2-Benzazepine Gly-Asp Mimetic,2000, J. Med. Chem. 43, 22-26.
Chen Barbara
Clare Michael
Gasiecki Alan F.
Khanna Ish Kumar
Lu Hwang-Fun
Habte Kahsay
Pharmacia Corporation
Polster Rachel A.
Raymond Richard L.
LandOfFree
Cycloalkyl alkanoic acids as integrin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cycloalkyl alkanoic acids as integrin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cycloalkyl alkanoic acids as integrin receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3367957